Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib.
Blood Cancer J
; 12(4): 73, 2022 04 22.
Article
in English
| MEDLINE | ID: covidwho-1799590
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Neoplasms
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Blood Cancer J
Year:
2022
Document Type:
Article
Affiliation country:
S41408-022-00651-3
Similar
MEDLINE
...
LILACS
LIS